Language selection

Search

Archived - Notice of Submission for Approval of Novel Food, Livestock Feed and Environmental Safety for Commercial Planting Purposes of a Plant Genetically Modified for Insect Resistant and Herbicide Tolerant Traits (MZIR098) from Syngenta Canada Inc.

This page has been archived

Information identified as archived is provided for reference, research or record-keeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Comment period closed: January 23, 2016

Background:

The CFIA and Health Canada (HC) have received a submission from Syngenta Canada Inc. seeking an environmental safety approval for commercial planting purposes and livestock feed and food use of a corn line designated as MZIR098, which has been genetically modified for insect resistance and herbicide tolerance. The submission received is in accordance with CFIA guidelines for assessment of plants with novel traits (PNTs) for unconfined release, CFIA guidelines for assessment of novel feeds from plant sources, and HC guidelines for assessment of novel foods. To view information related to the environmental assessment of a PNT or a novel feed from plant sources, please refer to the CFIA Web site. To view the information related to the health and safety assessment of a novel food, please refer to the Health Canada Web site.

Summary of the Submission Package

Updated scientific information may be added to this submission by the developer at a later date, or CFIA and/or Health Canada may request further information from the developer.

Description of the host plant

Please refer the Canadian Food Inspection Agency's Biology Document BIO1994–11: The Biology of Zea mays (L.) (Maize)

Description of the Modification

The PNT was developed through recombinant DNA technology. In order to assess the modification process, the following has been submitted:

Inheritance and Stability of the Introduced Trait

In order to assess the inheritance and stability of the genetic modification, the following has been submitted:

Description of the Novel Traits

In order to characterize the DNA inserted in the plant, the following has been submitted:

Nutritional Evaluation of the Novel Plant

In order to demonstrate the nutritional aspects of the novel plant are the same, the following has been submitted:

Absence of Allergenicity/Toxicity

In order to assess the absence of allergenicity and toxicity of the expressed genetic components, the following has been submitted or previously submitted, reviewed and published:

Evaluation of the Environmental Impact of the Novel Plant

In order to assess the environmental impact of the novel plant, the following has been submitted or previously submitted:

Comments will be received only via the Internet to CFIA or Health Canada.

For more information on this product, please contact:

Syngenta Canada Inc.
140 Research Lane
Guelph ON N1G 4Z3

1-87-SYNGENTA / 1-877-964-3682

The CFIA and Health Canada, including their employees, are not responsible for the content of this Notice of Submission as submitted by the Applicant. All Notices of Submission are the responsibility of the Applicant submitting them and the Applicant does so at its own risk. Submission of this Notice of Submission and its subsequent posting by the CFIA on its Web site does not in any way whatsoever constitute acceptance, approval or certification by the CFIA or Health Canada of the Plant with Novel Trait(s) subject of the Notice of Submission and the CFIA and Health Canada reserve all their rights under all the pertinent legislation that may be applicable. The CFIA and Health Canada in no way whatsoever waives any of their rights under any of the legislation they enforce or administer by way of the CFIA posting this Notice of Submission.

The Applicant is not obliged to provide any information. The Applicant submits information that it chooses to submit. The information that the Applicant voluntarily provides on this Notice of Submission is collected by the CFIA and Health Canada for the purpose of sharing information with the public. Personal Information will be protected under the provisions of the Privacy Act, and will be stored in Personal Information Bank CFIA PPU 125. Information, including personal information, may be accessible or protected as required under the provisions of the Access to Information Act.

Date modified: